When to implant an ICD in patients with heart failure and reduced ejection fraction? Insights from the HF-OPT trial.

Back

EHRA Premium Access

When to implant an ICD in patients with heart failure and reduced ejection fraction? Insights from the HF-OPT trial.

Session: Ventricular tachycardia 4

Topic: Device Treatment

Speaker: Professor C. Veltmann (Bremen, DE)

Event: EHRA 2024

Congress Presentation

About the speaker

Professor Christian Veltmann

Heart Center Bremen, Bremen (Germany)

10 presentations

1 follower

8 more presentations in this session

Cryoablation of ventricular tachycardia using ultra-low temperature technology: acute success and insights from the post-interventional CMR

Speaker: Associate Professor B. Dinov (Giessen, DE)

Safety and feasibility concerns of radiotherapy in the presence of subcutaneous implantable cardioverter-defibrillator

Speaker: Assistant Professor M. Tajstra (Zabrze, PL)

Cardiac tumors with life threatening arrhythmia, an eight year single centre experience

Speaker: Doctor O. Kamel (Aswan, EG)

Coronary venous ethanol ablation of refractory left ventricular summit arrhythmias: comparison with radiofrequency ablation

Speaker: Doctor M. De Smet (Brugge, BE)

THerapy Efficacy in Short or long-coupled idiopathic ventricular fibrillation: an International Survey (THESIS)

Speaker: Doctor O. Tovia Brodie (Jerusalem, IL)

Access the full session

Ventricular tachycardia 4

Speakers: Professor C. Veltmann, Associate Professor B. Dinov, Assistant Professor M. Tajstra, Doctor O. Kamel, Doctor M. De Smet...

Access

About the event

EHRA 2024

7 April - 9 April 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources